Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Disease severity in Ankylosing...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Disease severity in Ankylosing Spondylitis: The influence of associated inflammatory bowel disease and psoriasis
Bibliographic Details
Main Authors:
Bradbury, L
,
Lewington, M
,
Warner, J
,
Farrar, C
,
Wordsworth, B
,
Brown, M
Format:
Journal article
Published:
2008
Holdings
Description
Similar Items
Staff View
Similar Items
IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS), ADALIMUMAB IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (Ps) AND PREVENTS ANTERIOR UVEITIS (AU) FLARES
by: Wordsworth, P, et al.
Published: (2009)
Ankylosing spondylitis (AS) in inflammatory bowel disease (IBD) is associated with possession of HLA-B27 and DR1
by: Orchard, T, et al.
Published: (1997)
Adalimumab (HUMIRA (R)) improves inflammatory bowel disease (IBD) and psoriasis (Ps) and prevents anterior uveitis (AU) flares in patients with Ankylosing spondylitis (AS)
by: Rudwaleit, M, et al.
Published: (2008)
Towards defining the genetic determinants of disease severity in ankylosing spondylitis
by: Brophy, S, et al.
Published: (2001)
Towards defining the genetic determinants of disease severity in ankylosing spondylitis.
by: Brophy, S, et al.
Published: (2001)